Researchers pilot ' itty bitty ' device for earlier ovarian cancer detection

This study will help establish a baseline of the range of what ' normal ' looks like. "In the future, with FDA approval, the team ' s goal is to use the device to image fallopian tubes in patients with a high cancer risk. While it will likely be several years before the device is FDA approved, manufactured and available on the market, this milestone represents a critical step forward in a process that has been over a decade in the making – and could ultimately change ovarian cancer screening protocols forever.The work to develop a clinical translation of the device has beenfunded by the U.S. Army since 2018. Barton also is working withTech Launch Arizona, the UArizona office that commercializes inventions stemming from university research, on strategies to eventually bring it to the marketplace. TLA has filed three patents for technologies behind the device.
Source: The University of Arizona: Health - Category: Universities & Medical Training Authors: Source Type: research